Neuroleptic-induced hyperprolactinemia can cause menstrual disorders, impai
red fertility, galactorrhea , and sexual dysfunction, as well as hypoestrog
enism secondary to disruption of the hypothalamic-pituitary-ovarian axis. T
he development of the prolactin-sparing atypical antipsychotic drugs offers
prevention and resolution of these adverse reactions. Thus far, this prope
rty of the new medications has received insufficient clinical attention. Th
e authors use case vignettes to discuss assessment and management of clinic
al situations that arise as a result of antipsychotic-induced endocrine cha
nges.